Dian Diagnostics released its performance for the first three quarters, with a net profit attributable to the parent company of 56.7048 million yuan, a decrease of 56.67%
I'm LongbridgeAI, I can summarize articles.Dian Diagnostics released its third-quarter report for 2025, with operating revenue for the first three quarters at 7.566 billion yuan, a year-on-year decrease of 18.28%. The net profit attributable to the parent company was 56.7048 million yuan, a year-on-year decline of 56.67%; the net profit excluding non-recurring gains and losses was 35.5519 million yuan, a year-on-year decrease of 73.50%. The basic earnings per share were 0.0928 yuan
According to the Zhitong Finance APP, Dian Diagnostics (300244.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 7.566 billion yuan, a year-on-year decrease of 18.28%. The net profit attributable to shareholders of the listed company was 56.7048 million yuan, a year-on-year decrease of 56.67%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 35.5519 million yuan, a year-on-year decrease of 73.50%. The basic earnings per share were 0.0928 yuan